Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Lung Cancer

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 31 articles:
HTML format



Single Articles


    October 2026
  1. YANG B, Yang Y, Wang W, Wang Y, et al
    Effect of xeroderma pigmentosum group C on the characteristics and regulatory mechanisms of lung cancer stem cells.
    Int J Oncol. 2026;69:120.
    PubMed     Abstract available


  2. YIMING Z, Jie L
    MicroRNA regulation of macrophage polarization in lung cancer: Regulatory networks and therapeutic potential (Review).
    Int J Oncol. 2026;69:121.
    PubMed     Abstract available


    September 2026
  3. ZHU J, Chen M, Chen N, Ma A, et al
    [Retracted] Glycyrrhetinic acid induces G1?phase cell cycle arrest in human non?small cell lung cancer cells through endoplasmic reticulum stress pathway.
    Int J Oncol. 2026;69:97.
    PubMed     Abstract available


  4. XU Y, Duan H, Lu P, Liu F, et al
    The neural stem cell?NSCLC axis: Molecular drivers, microenvironment crosstalk and emerging therapies (Review).
    Int J Oncol. 2026;69:102.
    PubMed     Abstract available


    August 2026
  5. CHUANG TH, Guo JH, Yang JX, Tseng JC, et al
    PDLIM2 acts as a central regulator of ubiquitination, immune signaling, and mitochondrial metabolism in lung cancer suppression (Review).
    Int J Oncol. 2026;69:96.
    PubMed     Abstract available


    April 2026
  6. WEI Q, Huang C, Zhang Y, Zeng H, et al
    IL?6: A key player in the EGFR?TKI?resistant tumor microenvironment and its therapeutic implications (Review).
    Int J Oncol. 2026;68:47.
    PubMed     Abstract available


    February 2026
  7. PANG X, Liu H, Long Y, Wang H, et al
    mTOR in radiotherapy of lung cancer: Mechanisms of radiation resistance and therapeutic implications (Review).
    Int J Oncol. 2026;68:21.
    PubMed     Abstract available


  8. GAO J, Mcconnell MJ, Yu B, Li J, et al
    [Expression of Concern] MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion.
    Int J Oncol. 2026;68:16.
    PubMed     Abstract available


    January 2026
  9. LIU L, Yang L, Li H, Shang T, et al
    The tumor microenvironment in lung cancer: Heterogeneity, therapeutic resistance and emerging treatment strategies (Review).
    Int J Oncol. 2026;68:11.
    PubMed     Abstract available


    December 2025
  10. LI X, Wang J, Ge W, Chen X, et al
    Exosomal microRNAs: A new role in the diagnosis and treatment of lung cancer metastases (Review).
    Int J Oncol. 2025;67:101.
    PubMed     Abstract available


    October 2025
  11. WANG F, Hu S, Bian J, Gao Q, et al
    Notch3 mediated TGF?beta1 activation enhances epithelial?mesenchymal transition and cancer stemness in non?small lung cancer.
    Int J Oncol. 2025;67:85.
    PubMed     Abstract available


    August 2025
  12. LI Z, Zhang H, Chen Z, Wu G, et al
    MicroRNA?21: A potential therapeutic target in lung cancer (Review).
    Int J Oncol. 2025;67:67.
    PubMed     Abstract available


    June 2025
  13. WANG SQ, Zhao BX, Liu Y, Wang YT, et al
    [Corrigendum] New application of an old drug: Antitumor activity and mechanisms of doxycycline in small cell lung cancer.
    Int J Oncol. 2025;66:48.
    PubMed     Abstract available


  14. SHEN W, Pang H, Xin B, Duan L, et al
    [Corrigendum] Biological effects of BMP7 on small?cell lung cancer cells and its bone metastasis.
    Int J Oncol. 2025;66:51.
    PubMed     Abstract available


    May 2025
  15. YAN H, He Q, Gao Y, He X, et al
    SLC4A7 suppresses lung adenocarcinoma oncogenesis by reducing lactate transport and protein lactylation.
    Int J Oncol. 2025;66:33.
    PubMed     Abstract available


    April 2025
  16. ZHENG Y, Wang K, Mao W, Zhang G, et al
    Abnormal expression of CDC25C in NSCLC is influenced by transcriptional and RNA N6?methyladenosine?mediated post?transcriptional regulation.
    Int J Oncol. 2025;66:27.
    PubMed     Abstract available


  17. KAEWPIBOON C, Surapinit S, Malilas W, Moon E, et al
    [Retracted] Feroniellin A?induced autophagy causes apoptosis in multidrug?resistant human A549 lung cancer cells.
    Int J Oncol. 2025;66:30.
    PubMed     Abstract available


    March 2025
  18. XI Y, Zeng S, Tan X, Deng X, et al
    Curcumin inhibits the activity of ubiquitin ligase Smurf2 to promote NLRP3?dependent pyroptosis in non?small cell lung cancer cells.
    Int J Oncol. 2025;66:21.
    PubMed     Abstract available


  19. ANDREIKOS D, Spandidos DA, Georgakopoulou VE
    Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review).
    Int J Oncol. 2025;66:23.
    PubMed     Abstract available


    January 2025
  20. KIM H, Jung SH, Jo S, Han JW, et al
    Anti?angiogenic effect of Bryopsis plumosa?derived peptide via aquaporin 3 in non?small cell lung cancer.
    Int J Oncol. 2025;66:5.
    PubMed     Abstract available


  21. WANG Y, Fleishman JS, Li Y, Cao Y, et al
    Non?coding RNA?mediated epigenetic modification of ferroptosis in non?small cell lung cancer (Review).
    Int J Oncol. 2025;66:8.
    PubMed     Abstract available


    November 2024
  22. SUN Y, Lian Y, Mei X, Xia J, et al
    Cinobufagin inhibits M2?like tumor?associated macrophage polarization to attenuate the invasion and migration of lung cancer cells.
    Int J Oncol. 2024;65:102.
    PubMed     Abstract available


    August 2024
  23. ZHANG W, Liu K, Pei Y, Ma J, et al
    [Retracted] Mst1 regulates non?small cell lung cancer A549 cell apoptosis by inducing mitochondrial damage via ROCK1/F?actin pathways.
    Int J Oncol. 2024;65:75.
    PubMed     Abstract available


  24. WU S, Zhao Q, Liu S, Kuang J, et al
    Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non?small cell lung cancer.
    Int J Oncol. 2024;65:77.
    PubMed     Abstract available


    July 2024
  25. TAYLOR J, Dubois F, Bergot E, Levallet G, et al
    Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review).
    Int J Oncol. 2024;65:68.
    PubMed     Abstract available


    June 2024
  26. TAI F, Zhai R, Ding K, Zhang Y, et al
    Long non?coding RNA lung cancer?associated transcript 1 regulates ferroptosis via microRNA?34a?5p?mediated GTP cyclohydrolase 1 downregulation in lung cancer cells.
    Int J Oncol. 2024;64:64.
    PubMed     Abstract available


    April 2024
  27. XIE L, Xie D, Du Z, Xue S, et al
    A novel therapeutic outlook: Classification, applications and challenges of inhalable micron/nanoparticle drug delivery systems in lung cancer (Review).
    Int J Oncol. 2024;64:38.
    PubMed     Abstract available


    March 2024
  28. LI S, Li Z, Huang L, Geng Z, et al
    SLCO4A1, as a novel prognostic biomarker of non?small cell lung cancer, promotes cell proliferation and migration.
    Int J Oncol. 2024;64:30.
    PubMed     Abstract available


  29. WU G, Wang D, Xiong F, Wang Q, et al
    The emerging roles of CEACAM6 in human cancer (Review).
    Int J Oncol. 2024;64:27.
    PubMed     Abstract available


    December 2023
  30. SHIE WY, Chu PH, Kuo MY, Chen HW, et al
    Acidosis promotes the metastatic colonization of lung cancer via remodeling of the extracellular matrix and vasculogenic mimicry.
    Int J Oncol. 2023;63:136.
    PubMed     Abstract available


    November 2023
  31. HU X, Ren J, Xue Q, Luan R, et al
    Anti?PD?1/PD?L1 and anti?CTLA?4 associated checkpoint inhibitor pneumonitis in non?small cell lung cancer: Occurrence, pathogenesis and risk factors (Review).
    Int J Oncol. 2023;63:122.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum